Release Date: 23/02/12 16:16 Summary: Interim Financial Report December 2011 Price Sensitive: No Download Document 678.02KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%